A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer
Titel:
A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m2 Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer
Auteur:
Curtis, Kelly K. Hartney, Jean T. Jewell, Roxanne C. Park, Jung W. Lebowitz, Peter F. Griffin, Pamela P. Borad, Mitesh J. Fitch, Tom R. Northfelt, Donald W.